Stephanie Blank, MD
Gynecologic Oncology · New York, NYNPI 1043211626
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $229 of the $301 with a category attached, or 76.3%. 3 manufacturers reported payments, led by Biontech SE at 50.9% of the total. 2025 is the largest year on record at $153, 6.4 times the $24 reported in 2019. That places this record below the midpoint for gynecologic oncology clinicians in NY, where the typical reported total is $904.
Across 6 payments — averaging $50.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biontech SE$153
- Intuitive Surgical$95
- GSK$52
Across 478 payments — averaging $6943.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.3M
- GSK$564K
- Seagen Inc.$416K
- Genentech, Inc.$351K
- AstraZeneca$268K
- Tesaro, Inc.$122K
- plus $267K from 7 others
What the payments were for
- Food & beverage$22976%
- Education$7124%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biontech SE | 1 | $153 |
| Intuitive Surgical | 3 | $95 |
| GSK | 2 | $52 |
How this compares
$301 in reported general payments places this provider in the 30th percentile of 154 gynecologic oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in New York
- Bhavana PothuriNew York$366K
- Mario LeitaoNew York$116K
- Konstantin ZakashanskyNew York$93K
- Evelyn CantilloNew York$79K
- Farr NezhatNew York$41K
- Kristen ZeligsNew York$38K
- Nimesh NagarshethNew York$33K
- Jeff LinNew York$30K
- Valentin KolevNew York$23K
- Jason WrightNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.